OSSTEC

📍 London, United Kingdom🗓 Founded 2021👥 12 employees💰 Last funded Mar 2023
Osteoarthritis causes chronic pain for 33% of the population and is treated with joint replacement. 1.3M knee replacements are performed globally every year - 450,000 of them are in young patients with high risk of failure and revision surgery. These patients experience poorer outcomes so surgeons are reluctant to treat them. OSSTEC has developed an additive manufacturing bone healing technology, currently applied in partial knee implants. Our implants stimulate long-term bone growth to resolve common sources of failure: loosening and bone loss. Our vision is to keep patients active, pain-free and enjoying added years of improved quality of life.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in OSSTEC?
OSSTEC has 1 investors on record on gritt.io, including 1 early-stage backers.
When did OSSTEC last raise funding?
The most recent investment in OSSTEC recorded on gritt.io was in March 2023.
When was OSSTEC founded?
OSSTEC was founded in 2021.
What industry is OSSTEC in?
OSSTEC operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is OSSTEC based?
OSSTEC is headquartered in London, United Kingdom.